HAEMATOKINE

Welcome to the Brand page for “HAEMATOKINE”, which is offered here for Pharmaceuticals, medical and veterinary preparations for the treatment of hematological malignancies, bone marrow dysfunction or suppressions; sanitary preparations for medical purposes; stem cells for medical or veterinary use; stem cells for medical purposes; tumor suppressing agents; pharmaceutical preparations, antineoplastics; anti-neoplastic preparations of chemical origin, pharmaceutical preparations for hematological malignancies, bone marrow dysfunction or suppressions; anti-neoplastic preparations of microbial origin, pharmaceutical preparations for hematological malignancies, bone marrow dysfunction or suppressions; anti-cancer preparations; compounds for treating cancer, anti-cancer preparations; antibodies for medical purposes for the treatment of hematological malignancies, bone marrow dysfunction or suppressions; antibodies for medical use to treat inflammation and cancer growth and spread; adjuvants for medical purposes; vaccine adjuvants; biological adjuvants for medical purposes; anti-inflammatories; antigens, tumour antigens for medical diagnostic purposes; biological preparations for the treatment of cancer; biopharmaceuticals for the treatment of cancer; biotechnological preparations for medical use, biological preparations for the treatment of conditions associated with poor production of hematopoietic stem cells; culture media for medical use, culture media for use in augmentation of blood cells, bone marrow and tissues for medical purposes; media for bacteriological cultures; cell growth media for growing cells for medical use; biological preparations for medical purposes, biological preparations for the treatment of hematological malignancies, bone marrow dysfunction or suppressions; mixed biological preparations for medical purposes, mixed biological preparations for the prevention and treatment of infectious diseases; biological preparations for veterinary purposes, biological preparations for the treatment of hematological malignancies, bone marrow dysfunction or suppressions; pharmaceutical preparations, immunomodulators; immunostimulants; injectable pharmaceuticals for treatment of hematological malignancies, bone marrow dysfunction or suppressions; pharmaceutical preparations for the treatment of viral diseases; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for activating cellular function; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the prevention of tumours; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances with anti-inflammatory properties for treatment of hematological malignancies, bone marrow dysfunction or suppressions; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the prevention of diseases of the immune system; pharmaceutical preparations for the prevention of disorders of the immune system; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of disorders caused by bacteria; pharmaceutical preparations for the treatment of diseases caused by bacteria; pharmaceutical preparations for the prevention of disorders of the respiratory system; pharmaceutical preparations for the prevention of inflammatory disorders; pharmaceutical preparations for the prevention of autoimmune disorders; pharmaceutical preparations for the prevention of inflammatory diseases; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in tissue transplantation; pharmaceutical products for the treatment of bone diseases; regulatory proteins for medical use, protein arrays for medical diagnosis purposes; serotherapeutic medicines, pharmaceutical preparations for the treatment of hematological malignancies, bone marrow dysfunction or suppressions; synthetic peptides for pharmaceutical purposes for the treatment of hematological malignancies, bone marrow dysfunction or suppressions; pharmaceutical products for treating respiratory diseases; pharmaceutical compounds for treating respiratory diseases; pharmaceutical preparations for treating respiratory diseases; pharmaceutical compounds for treating correlated pulmonary syndromes; pharmaceutical preparations for treatment and prevention of ischemic conditions, inflammation and organ damages resulting from tissue traumas, reperfusion injuries, cancer, cancer metastasis, inflammatory conditions and allergic conditions; pharmaceutical preparations for treatment and prevention of multi-organ failure, acute lung injury and acute respiratory distress syndrome in adults, adolescents, children, infants and neonates;chemicals for use in industry, science and photography, as well as in agriculture, horticulture and forestry, except fungicides, herbicides, insecticides and parasiticides; biological preparations for use in industry and science; media for cell culture for use in the biotechnological industry, cell culture media for scientific and research use; media for cell culture for use in non-medical research laboratories, cell culture media for laboratory use; biological preparation for use in cell cultures other than for medical or veterinary use; culture media for microbiology, for scientific and research use; cell growth media for growing cells for scientific use; biological preparation for use in cell cultures, other than for medical or veterinary use; cultures of cell media other than for medical or veterinary use, culture media for scientific and research use; cultures of microorganisms, other than for medical and veterinary use; blood culture media being cell culture media for scientific use; biological preparations for use in cell cultures, other than for medical or veterinary purposes; stem cells, other than for medical or veterinary purposes; stem cells for scientific purposes; stem cells for research purposes;.

Its status is currently believed to be active. Its class is unavailable. “HAEMATOKINE” is believed to be currently owned by “Faron Pharmaceuticals Oy”.